REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/03/2025
Back to search
Official data from USPTO
IMMUNOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
03/04/2025
Trademark type
Word
Nice classes
42
Filing date
05/31/2016
Registration date
03/03/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/03/2020
Last transaction
03/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/21/2019
First use in commerce
10/21/2019
Drawing code
4
Owner type
03
Owner location
Exton, PA
Examiner
RINKER, ANTHONY
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Immunome Inc.
Immunome Inc.
Representatives
LORI J. SHYAVITZ MCCARTER & ENGLISH, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biotechnology servicesdevelopment of monoclonal antibodies; pharmaceuticalmedicalscientificbiopharmaceutical and biotechnology research and development; drug discovery services; providing medical and scientific research information in the field of medicine and pharmaceuticals
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/28/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/27/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/04/2020
IUAF
USE AMENDMENT FILED
01/03/2020
EISU
TEAS STATEMENT OF USE RECEIVED
01/03/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/06/2019
EX5G
SOU EXTENSION 5 GRANTED
07/05/2019
EXT5
SOU EXTENSION 5 FILED
07/03/2019
EEXT
SOU TEAS EXTENSION RECEIVED
07/03/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/04/2019
EX4G
SOU EXTENSION 4 GRANTED
01/02/2019
EXT4
SOU EXTENSION 4 FILED
01/02/2019
EEXT
SOU TEAS EXTENSION RECEIVED
01/02/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/03/2018
EX3G
SOU EXTENSION 3 GRANTED
06/29/2018
EXT3
SOU EXTENSION 3 FILED
06/29/2018
EEXT
SOU TEAS EXTENSION RECEIVED
06/29/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/18/2018
NOAC
CORRECTED NOA E-MAILED
01/18/2018
EX2G
SOU EXTENSION 2 GRANTED
01/17/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
01/17/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/16/2018
EXT2
SOU EXTENSION 2 FILED
01/03/2018
DRRR
DIVISIONAL REQUEST RECEIVED
01/03/2018
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/03/2018
EEXT
SOU TEAS EXTENSION RECEIVED
01/03/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/05/2017
EX1G
SOU EXTENSION 1 GRANTED
07/03/2017
EXT1
SOU EXTENSION 1 FILED
07/03/2017
EEXT
SOU TEAS EXTENSION RECEIVED
07/03/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/03/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2016
PUBO
PUBLISHED FOR OPPOSITION
11/08/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/03/2016
ALIE
ASSIGNED TO LIE
09/30/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
09/16/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/16/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
09/16/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/16/2016
DOCK
ASSIGNED TO EXAMINER
09/13/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/07/2016
NWAP
NEW APPLICATION ENTERED
06/03/2016
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.